Abstract:Circulating tumor cells (CTCs) currently represent a revolutionary tool offering unique insights for the evaluation of cancer progression, metastasis, and response to therapies. Indeed, CTCs, upon detachment from primary tumors, enter the bloodstream and acquire a great potential for their use for personalized cancer management. In this review, we describe the current understanding of and advances in the clinical employment of CTCs. Although considered rare and fleeting, CTCs are now recognized as key players favoring the development of cancer metastasis and disease recurrence, particularly in malignant melanoma, lung, breast, and colorectal cancer patients. To date, the advancements in technology and the development of several successful approaches, also including immunomagnetic enrichment allow for a reliable and reproducible detection and characterization of CTCs. Those innovative methodologies improved the isolation, quantification, and characterization of CTCs from the blood of cancer patients, providing extremely useful evidence and new insights into the nature of the tumor, its epithelial/mesenchymal profile, and its potential resistance to therapy. In fact, in addition to their prognostic and predictive value, CTCs could serve as a valuable instrument for real-time monitoring of treatment response and disease recurrence, facilitating timely interventions and thus improving patient outcomes. However, despite their potential, several challenges hinder the widespread clinical utility of CTCs: (i) CTCs' rarity and heterogeneity pose technical limitations in isolation and characterization, as well as significant hurdles in their clinical implementation; (ii) it is mandatory to standardize CTC detection methods, optimize the sample processing techniques, and integrate them with existing diagnostic modalities; and (iii) the need for the development of new techniques, such as single-cell analysis platforms, to enhance the sensitivity and specificity of CTC detection, thereby facilitating their integration into routine clinical practice. In conclusion, CTCs represent a potential extraordinary tool in cancer diagnostics and therapeutics, offering unprecedented opportunities for personalized medicine and precision oncology. Moreover, their ability to provide real-time insights into tumor biology, treatment response, and disease progression underlines a great potential for their clinical application to improve patients' outcomes and advance our understanding of cancer biology.

Circulating Tumor Cells: Origin, Role, Current Applications, and Future Perspectives for Personalized Medicine

Circulating Tumor Cells in Prostate Cancer Diagnosis and Monitoring: An Appraisal of Clinical Potential

Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors

Circulating Tumor Cells: A New Window For Diagnosis And Evaluation Of Cancer

Advancements in Circulating Tumor Cell Research: Bridging Biology and Clinical Applications

Position of Circulating Tumor Cells in the Clinical Routine in Prostate Cancer and Breast Cancer Patients

Circulating Tumor Cells: How Far Have We Come with Mining These Seeds of Metastasis?

Circulating tumor cells: biology and clinical significance

Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance

Circulating Tumor Cells (CTCs): A Unique Model of Cancer Metastases and Non-invasive Biomarkers of Therapeutic Response

Molecular Characterization of Circulating Tumor Cells-from Bench to Bedside

Clinical Applications Of Circulating Tumor Cells In Pharmacotherapy: Challenges And Perspectives

Circulating Tumor Cells in Gastrointestinal Cancers: Current Status and Future Perspectives

Unveiling the dynamics of circulating tumor cells in colorectal cancer: from biology to clinical applications

Circulating and Disseminated Tumor Cells: Diagnostic Tools and Therapeutic Targets in Motion

Detection of circulating tumor cells: opportunities and challenges

Tracking cancer progression: from circulating tumor cells to metastasis

Progress of Circulating Tumor Cells in Clinical Application

Circulating Tumor Cells in Precision Oncology: Clinical Applications in Liquid Biopsy and 3D Organoid Model

Circulating Tumor Cells and Individualized Chemotherapy

The Role of Circulating Tumor Cells as a Liquid Biopsy for Cancer: Advances, Biology, Technical Challenges, and Clinical Relevance